Symbolbild · KI-generiert
Hikma Pharmaceuticals
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. We do not have a verified market capitalisation for this company.
Company profile
Hikma Pharmaceuticals is a multinational pharmaceutical manufacturer focused on generics, branded medicines and injectable drugs. The company operates principally in the US, Europe and the MENA region, with core areas including intravenous generics and branded prescription products.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Hikma Pharmaceuticals | HIK | LSE | — |
| 4DMEDICAL LIMITED | 4DX | ASX | — |
| Abcam | LSE | — | |
| Accor | AC | Euronext Paris | — |
| Alexion Pharmaceuticals | ALXN | NASDAQ | — |
| Amicus Therapeutics | FOLD | NASDAQ | — |
| Ansell | ANN | ASX | — |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.